Biomarker Study for Heart Failure in Children With Single Ventricle Physiology

Completed

Conditions studied: Tricuspid Atresia, Hypoplastic Left Heart Syndrome, Unbalanced AV Canal

In brief

The purpose of this study is to determine if children with heart disease where there is only one pumping chamber("ventricle") have proteins (biomarkers") in the blood that can be used to monitor the function of their heart.

Key facts

Study ID

NCT00571233

Run by

University of California, San Francisco

People needed

71

Starts

2007-02-01

Expected to finish

2015-01-01

Last updated by the study team

2015-05-14

Who can join

Age: 0 and older, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children with a structurally normal heart and a patent ductus arteriosus.
• Children with single ventricle physiology.

You may not qualify if…

• Children must not have chromosomal abnormalities. Small deletions, such as that which produces DiGeorge syndrome, are permissible.
• Children with acute intercurrent non-cardiac inflammatory illness (such as post-operative wound infection) are ineligible, as such conditions may cause elevated blood levels of the proteins under study.

Where it is running

• Pediatric Heart Center, University of California, San Francisco — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.